Why auricular cartilage is the right biological seed

What the ear offers that joint cartilage cannot

Articular cartilage has almost no capacity for self-repair. Mature joint cartilage is avascular, aneural, and — unlike most living tissue — entirely lacks a perichondrium: the cellular envelope that elsewhere supplies resident progenitor cells. When damaged, a joint surface cannot call on a local reserve of undifferentiated cells to rebuild itself. This is the fundamental biological problem that cartilage surgery has always had to solve.

The ear addresses it directly. Auricular cartilage retains its perichondrial envelope throughout adult life — a continuous bilayer wrapping whose inner, chondrogenic layer harbours undifferentiated progenitors capable of forming new chondrocytes. Gram for gram, this tissue holds more regenerative potential than the smooth hyaline cartilage inside a joint.

NanoACi — Professor Paul Lee's autologous chondrogenic injection technique, surgeon-led, non-arthroscopic and needle-delivered in one planned sitting — designates mechanically prepared auricular cartilage micrografts as the 'Seed': the regenerative component in a three-part autologous construct. The choice rests on four compounding advantages that converge at the ear:

• Biology: a progenitor-rich perichondrial anatomy unavailable in mature joint cartilage
• Lineage: a uniquely plastic embryological origin that equips the cells to adapt to a new joint environment
• Practicality: a straightforward, point-of-care harvest with no enzyme digestion and no external laboratory
• Precedent: decades of established donor-site safety from routine ENT and plastic-surgery practice

Together, these make the ear an exceptional — and perhaps counterintuitive — choice of graft source for joint cartilage repair.

The perichondrium: a bilayer progenitor reservoir

Two distinct layers make up the perichondrium, and they serve quite different purposes. The outer layer is fibrous — dense collagen fibres and fibroblasts that give the tissue structural integrity and anchor it to surrounding structures. The inner layer is where the regenerative value lies: a stratum of undifferentiated cells that can differentiate into chondroblasts, actively building and maintaining cartilage matrix. This inner chondrogenic layer is, in effect, a resident cell nursery sitting flush against the cartilage surface.

In auricular elastic cartilage, this inner layer persists continuously into adult life. Mature articular cartilage loses its perichondrium entirely as the skeleton develops; the ear does not. That distinction is anatomically significant, because the perichondrium is simultaneously the cartilage's only source of nutrients and oxygen — cartilage itself has no blood supply. Clinical evidence of this dependency is visible in cauliflower ear: a blunt blow forces blood between the cartilage and its perichondrial lining, severing the nutritive connection and causing the cartilage beneath to die. The deformity is the consequence of that separation.

This vascular dependency is, in the context of NanoACi, a point in the protocol's favour. Each 2.5 mm punch biopsy of the concha captures cartilage core and perichondrial lining together, intact. The progenitor cells arrive at the point-of-care preparation stage still connected to their native matrix — not isolated, not disrupted by enzyme digestion. Every micrograft is therefore enriched with chondrogenic cells from the moment of harvest, a biological richness that a biopsy of bare joint cartilage could not replicate.

Neural-crest origin and HOX-negativity: why ear cells are positionally plastic

The developmental history of a cell shapes what it can do in adult life. Auricular cartilage originates from neural-crest cells — a migratory embryological population entirely separate from the mesodermal lineage that generates all limb and trunk cartilage, including articular cartilage. That lineage difference has a direct consequence: neural-crest chondrocytes are HOX-gene-negative.

HOX genes encode positional identity — the molecular address that commits a cell to one anatomical location and, by extension, one functional programme. Limb cartilage is HOX-positive; its cells carry a fixed developmental address. Ear cartilage is HOX-negative; its cells carry none. Without a fixed positional address, they retain an unusual capacity to read environmental signals in a new location and reconfigure their behaviour accordingly — adapting to the demands of a joint surface rather than defaulting to ear-specific programming.

This is not a theoretical property. A research group in Basel demonstrated experimentally that adult human neural-crest-derived cartilage cells transplanted into a joint environment could repair articular cartilage, effectively adopting the identity of the resident joint cells.

Beyond positional plasticity, neural-crest chondrocytes outperform articular chondrocytes across the metrics that matter for regeneration:

• Higher and more reproducible chondrogenic potential
• Superior proliferative capacity and more stable chondrogenic differentiation
• Resistance to dedifferentiation — the tendency of expanded joint cells to revert to a fibroblast-like state
• Reliable production of type II collagen and proteoglycan: the structural proteins of healthy cartilage matrix

This combination of adaptability and chondrogenic performance is precisely what a graft must offer when asked to integrate into an established joint surface.

From ear to joint: how anatomy enables a one-stage protocol

Three punch biopsies — each approximately 2.5 mm across — taken from the concha under local anaesthetic: that is the entirety of the harvest step. The site is superficial, concealed within the fold of the ear, and heals within a week. No general anaesthetic is required. ENT and plastic surgeons have routinely used this same donor tissue for nasal reconstruction for decades, establishing a long track record of donor-site safety that NanoACi directly inherits.

Because the concha's anatomy delivers both the cartilage core and the perichondrial lining in a single pass, no additional dissection is needed to enrich the micrograft. The progenitor-laden inner layer arrives intact, still integrated with its native matrix.

Those samples then undergo mechanical disaggregation using the Mytocel MSK system, built on Remedi's Rigenera Autologous Micrografting Technology (AMT), at the point of care on the day of treatment. There is no enzyme digestion, no expansion in external culture, and no laboratory stage. This is a deliberate design choice: mechanical preparation preserves cell-membrane integrity and retains the perichondrium-derived progenitors within the micrograft, avoiding the dedifferentiation risk that enzymatic and culture-based methods can introduce into expanded articular chondrocytes.

The result is a perichondrium-inclusive autologous micrograft suspension, ready to be combined with the collagen scaffold and platelet-rich fibrin signal within the same planned sitting. Specialist preparation, sequencing, and image-guided delivery remain essential throughout — needle access is the route; the clinical judgement and protocol discipline that surrounds it are what make the procedure work.

The concha as a donor site: proven safety and minimal morbidity

Conchal cartilage carries a safety record that predates NanoACi by several decades. ENT surgeons and plastic surgeons have used it routinely for nasal reconstruction — rebuilding dorsal supports, tip frameworks, and sidewalls in both primary rhinoplasty and revision cases. That accumulated surgical practice, spanning generations of reconstructive work, establishes the concha as a donor site whose credentials are documented rather than assumed: accessible under local anaesthetic, reliable in yield, and tolerant of harvest without consequence to the surrounding structure.

Three features of that inherited record bear directly on patient questions. First, removing a small amount of conchal cartilage does not alter the shape or contour of the outer ear — the remaining architecture is more than sufficient to maintain it. Second, the harvest has no effect on hearing: the concha plays no role in sound conduction. Third, the incision is placed within the natural fold of the ear, so any mark is concealed once healing is complete.

Donor-site morbidity is low and well characterised in the pre-existing surgical literature. NanoACi draws on this established precedent rather than asking patients to accept an untested donor site. The confidence behind the harvest step was earned by reconstructive surgeons long before cartilage regeneration entered the picture; NanoACi extends it into a new application.

Clinical evidence supporting auricular micrografts in knee cartilage

Three peer-reviewed human studies have examined auricular cartilage micrografts applied to knee cartilage pathology, each adding a layer of clinical weight to the biological rationale covered in earlier sections.

Marcarelli et al. (Journal of Clinical Medicine, 2021) followed patients over three years and recorded improvements in patient-reported outcome measures alongside measurable gain in MRI cartilage thickness — a signal that points beyond symptom relief toward structural change. Tsoukas et al. (Bioengineering, 2023) demonstrated pain and function improvement after a single intra-articular application in knee osteoarthritis. Helito et al. (Bioengineering, 2024) reported a pilot study further supporting micrografts for osteoarthritis pain.

These are component-level studies validating the Seed — the auricular micrograft arm of the protocol. Combined-protocol outcomes for the full three-part NanoACi construct are being developed through the NanoACi 100 outcomes programme, which reflects the technique's commitment to prospective measurement and to building the evidence base that patients and referring clinicians rightly expect.

The Marcarelli three-year MRI data offer the most concrete takeaway: ear-sourced micrografts, mechanically prepared and delivered on the day, produced cartilage thickness changes visible on imaging and sustained over follow-up. For patients whose own scans already show early cartilage loss, that finding — earned over three years in published research — is a meaningful reference point when considering a specialist consultation to determine whether NanoACi is appropriate for their joint and presentation.

1. [1] Perichondrium — Wikipedia. https://en.wikipedia.org/?curid=1220134 https://en.wikipedia.org/?curid=1220134